Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats

CG200745 is a novel inhibitor of histone deacetylases (HDACs), initially developed for treatment of various hematological and solid cancers. Because it is water-soluble, it can be administered orally. We hypothesized that the HDAC inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in d...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Korean J Physiol Pharmacol
Hoofdauteurs: Lee, Eunjo, Song, Min-ji, Lee, Hae-Ahm, Kang, Seol-Hee, Kim, Mina, Yang, Eun Kyoung, Lee, Do Young, Ro, Seonggu, Cho, Joong Myung, Kim, Inkyeom
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The Korean Physiological Society and The Korean Society of Pharmacology 2016
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014994/
https://ncbi.nlm.nih.gov/pubmed/27610034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2016.20.5.477
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items